ReviewF1000Research
Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases.
Review in F1000Research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Which way forward for Canada's vaccine injury support program?Canadian journal of public health = Revue canadienne de sante publique · 2026Article
- Comparison and consideration of vaccine injury compensation programs in the Republic of Korea, Japan, and Taiwan.Osong public health and research perspectives · 2024Article
- Descriptive cross-sectional study to evaluate perception, attitude, and practice of parents regarding COVID-19 vaccination in children 10-12 years of age-A step toward prevention of future COVID-19 outbreaks in India.Journal of family medicine and primary care · 2024Article
- COVID-19 Vaccine Injury Compensation Program: Lessons Learned From a Review of 10 Implementing Countries.Journal of Korean medical science · 2024Review
- A solution towards a viable compensation mechanism for injury from COVID-19 vaccines in Malaysia: A qualitative study.Heliyon · 2024Article
- Review
- A review of China's compensation program for adverse reactions following immunization.Frontiers in public health · 2023Review
- Observational
- COVID-19 Vaccination and Medical Liability: An International Perspective in 18 Countries.Vaccines · 2022Review
- No-Fault Compensation and Anti-COVID-19 Compulsory Vaccination: The Italian Context in a Broad View.Vaccines · 2022Article
- Reducing COVID-19 Vaccine Hesitancy From a Decisional Conflict Model: A Cross-Sectional Study.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.